ESC 365 - Comparison between cryoballoon and radiofrequency for atrial fibrillation ablation in patients with heart failure

EHRA Premium Access

Comparison between cryoballoon and radiofrequency for atrial fibrillation ablation in patients with heart failure

Session: ePosters Day 2

Topic: Rhythm Control, Catheter Ablation

Speaker: Professor H. Yorgun (Ankara, TR)

Event: EHRA 2022

Congress Presentation

About the speaker

Professor Hikmet Yorgun

Hacettepe University, Ankara (Türkiye)

0 follower

131 more presentations in this session

Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion

Speaker: Doctor L. Sgarra (Acquaviva Delle Fonti, IT)

Pure and impure tachycardiomiopathy: key differences and long term prognosis

Speaker: Doctor G. Stronati (Ancona, IT)

Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation

Speaker: Professor D. Lashkul (Zaporizhzhia, UA)

Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults

Speaker: Mr E. Abdovic (Zenica, BA)

CHA2DS2-VASc score and the risk of death in atrial fibrillation

Speaker: Doctor A. Aro (Helsinki, FI)

Access the full session

ePosters Day 2

Speakers: Professor H. Yorgun, Doctor L. Sgarra, Doctor G. Stronati, Professor D. Lashkul, Mr E. Abdovic...

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

Related content

EHRA Premium Access

Impact of high-power and very high-power short-duration radiofrequency ablation on procedure characteristics and first-pass isolation during pulmonary vein isolation

5 April 2022

EHRA Premium Access

Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping

3 April 2022

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

ESC 365 is supported by